However, a previous similar study (IRCT2013122811763N15) with 80 NAFLD patients supplemented with the same symbiotic, but with no sitagliptin, did not output changes in ALT or AST levels, showing only a significantly reduced steatosis on abdominal ultrasound [274]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.